Stocks
Amicus Therapeutics (FOLD) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 1 431% | 9 558% | 7 004% | 7 347% | 2 048% | 1 513% | |||
| Changes by years, y/y, % | -2 864pp | +8 127pp | -2 554pp | +342pp | -5 299pp | -13.8% | |||
Amicus Therapeutics. R&D/CAPEX, %
Amicus Therapeutics. R&D/CAPEX, changes, pp
Amicus Therapeutics (FOLD) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 2 601% | 2 024% | 1 564% | 2 248% | 899.3% | 1 513% | ||
| Changes by years, y/y, % | -36 063pp | -362pp | -573pp | +652pp | -1 702pp | |||
| Changes by quarters, q/q, % | +1 005pp | -577pp | -459pp | +684pp | -1 349pp | |||
